Clinical analysis of chemotherapy increases the risk of hepatic toxicity in hepatitis B virus antigen positive patients with lung cancer

LUO Jie; ZHENG Di; ZHOU Cai-cun

doi:10.3969/j.issn.1009-0460.2005.03.007

Home>Articles>Clinical analysis of chemotherapy increases the risk of hepatic toxicity in hepatitis B virus antigen positive patients with lung cancer

DOI: 10.3969/j.issn.1009-0460.2005.03.007

Clinical analysis of chemotherapy increases the risk of hepatic toxicity in hepatitis B virus antigen positive patients with lung cancer

LUO Jie

ZHENG Di

ZHOU Cai-cun

Machine-generated Keywords：

Publication Date：2005-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：3( 249-251 )

CHINESE CLINICAL ONCOLOGY

PKUISTIC

ISSN：1009-0460

Year, Vol.(Issue)：2005,10(3)